Clinical Trials

138 enrolled

Advanced/Metastatic Solid Tumors

NCT07475559 2026-03-16

JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors

42 enrolled

Advanced Solid Tumor Malignancies

NCT07469982 2026-03-13

A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors

122 enrolled

Advanced or Metastatic Solid Tumors With Homozygous MTAP Deletion

NCT07467629 2026-03-12

QLS5212 for Participants With Advanced Solid Tumors

100 enrolled

Solid Tumor Cancer

NCT07462442 2026-03-10

Study of QLS5308 in Patients With Advanced Solid Tumors

192 enrolled

Metastatic Solid Tumors

NCT07362888 2026-03-03

First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors

180 enrolled

Solid Tumors (Phase 1)

NCT07346846 2026-03-02

A Study of BGM-2121 in Patients With Advanced Solid Tumors

35 enrolled

Advanced Solid Tumors

NCT07443020 2026-03-02

RIOT 4B

Other solid neoplasmThoracic

10 enrolled

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT07176975 2026-02-27

A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers

46 enrolled

Solid Tumors

NCT07413328 2026-02-27

HWS116 Monotherapy in Patients With Advanced Solid Tumors

56 enrolled

Advanced Solid Tumors

NCT07434609 2026-02-25

Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors

150 enrolled

Advanced Solid Tumor (Phase 1)

NCT07414836 2026-02-17

A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors

84 enrolled

Advanced Solid Tumor

NCT07408258 2026-02-13

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

Advanced Solid Tumor

NCT07407504 2026-02-12

GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors.

186 enrolled

Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated

NCT07395258 2026-02-09

A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

60 enrolled

Solid Tumors

NCT07391644 2026-02-06

A Study of JSKN027 in Patients With Advanced Solid Tumors

250 enrolled

Advanced Malignant Solid Tumor

NCT07380334 2026-02-02

A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors

200 enrolled

Advanced Solid Tumor

NCT07363369 2026-01-23

Exploratory Clinical Study of FAP mRNA Vaccine in Patients With Advanced Malignant Solid Tumors

10 enrolled

Advanced Malignant Solid Tumors

NCT07348653 2026-01-21

A Study of MG2512 Injection in Participants With Advanced Solid Tumors

116 enrolled

Advanced Solid Tumor

NCT07356856 2026-01-21

Efficacy and Safety of Microtransplantation for Advanced and Relapsed Solid Tumors

10 enrolled

Advanced and Relapsed Solid Tumors

NCT07294872 2026-01-16

A Study of TIL in Advanced Solid Tumors (CZ)

Solid Tumor, Adult

NCT07345637 2026-01-16

FXS887-I101

14 enrolled

Solid Tumor Refractory to Conventional Treatment

NCT07256756 2025-12-23

A Study of GC203 TIL in Advanced Solid Tumors (NF)

8 enrolled

Solid Tumors, Adult

NCT07275853 2025-12-10

Personalized KXV01 Lentinvivo (TCR) Injection as the Therapy for Advanced Solid Tumors

Advanced Solid Tumors

NCT07262164 2025-12-03

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors

Advanced Malignant Solid Tumor

NCT07257497 2025-12-02

Safety and Efficacy of Combining a Vitamin B6-Limited Diet With Immunotherapy in Solid Tumor Patients: A Clinical Study Protocol

Solid Tumor Cancer

NCT06933524 2025-10-01

ATB-320-001A

24 enrolled

Solid Tumors

NCT07190833 2025-09-24

A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea)

27 enrolled

Treatment-Refractory Solid Tumors

NCT07118709 2025-08-12

A Study of KC1086 in Patients With Advanced Solid Tumors

66 enrolled

Advanced Solid Tumors Cancer

NCT07107178 2025-08-06

A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma

DermatologicOther solid neoplasm

58 enrolled

Advanced Melanoma

NCT07100925 2025-08-03

A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma

DermatologicOther solid neoplasm

Cutaneous Squamous Cell Carcinoma (CSCC)

NCT07101549 2025-08-03

Treating Nectin-4-positive Advanced Solid Tumors With R-Star001 (Nectin-4-CART-IL18)

25 enrolled

Advanced Solid Tumors

NCT07045428 2025-07-03

68Ga-GP-01 Injection in Solid Tumors Participants

Solid Tumor Malignancies

NCT06998173 2025-05-31

Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DAT-1604 in Advanced Solid Tumor

228 enrolled

Advanced Solid Tumors

NCT06963398 2025-05-09

A Study of HS-10529 in KRAS G12D Patients With Advanced Solid Tumors

520 enrolled

Advanced Solid Tumors

NCT06932094 2025-04-23

Phase 1 Clinical Study of QLS5132 Monotherapy in Advanced Solid Tumors

256 enrolled

Advanced Solid Tumors

NCT06925659 2025-04-17

A Study of QLM2011 in Subjects With Advanced Solid Tumors

172 enrolled

Advanced Solid Tumors

NCT06885645 2025-04-03

First-In-Human Study in Participants With Advanced Solid Tumors

Advanced Solid Tumors

NCT06872580 2025-03-12

A Study of QLS1209 in theTreatment of Patients With Advanced Solid Tumors

149 enrolled

Advanced Solid Tumor

NCT06800196 2025-01-29

A Study of KNT-0916 in Treatment of Unresectable or Metastatic Solid Tumors with FGFR2 Alterations

151 enrolled

Solid Tumors with FGFR2 Alterations, Adult

NCT06781125 2025-01-17

One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid Tumors

72 enrolled

Malignant Solid Tumors

NCT06779045 2025-01-16

A Study of AK-1286 in Patients With Advanced Solid Tumors

50 enrolled

Advanced Solid Tumor

NCT06752447 2024-12-30

A Phase I Study OfLNF2007 Monotherapy in Patients with Advanced Solid Tumors

94 enrolled

Advanced Solid Tumors (Phase 1)

NCT05954091 2024-12-27

OH2 Administered by Intratumoral Injection

29 enrolled

Solid Tumor

NCT06710821 2024-11-29

Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid Tumors

40 enrolled

Solid Tumor Cancer

NCT06652529 2024-11-07

AROG4-01-01

GastrointestinalGynecologicOther solid neoplasmThoracic

35 enrolled

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Ovarian Neoplasms, Colorectal Neoplasms

NCT06621615 2024-10-01

Clinical Study of CVL006 Injection in Advanced Solid Tumors

120 enrolled

Advanced Solid Tumor

NCT06598735 2024-09-19

A Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Initial Efficacy of HRS-4508 Monotherapy in Patients With Advanced or Metastatic Solid Tumors

100 enrolled

Advanced Solid Tumors

NCT06553846 2024-08-14

A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors

50 enrolled

Solid Tumors

NCT06533605 2024-08-01

Phase I Clinical Study to Evaluate the Safety and Efficacy of SSGJ-706 Monotherapy for Patients With Advanced Solid Tumors

60 enrolled